<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-12T00:47:50Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.41497" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.41497</identifier>
    <datestamp>2026-07-02T16:16:43Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2026-07-02</dc:date>
  <dc:title>Study on the Expression of Human &amp;beta;-Defensin-3 in  Sporotrichosis Lesions and Its Clinical Correlations</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.41497</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>1. Expression characteristics of hBD-3 in sporotrichosis lesions and its correlation with clinical characteristics: Compared with healthy controls, hBD-3 expression was significantly increased in sporotrichosis lesions (P &amp;lt; 0.0001), mainly localized to the spinous and basal layers of the epidermis. hBD-3 expression was higher in the early stage of disease duration (&amp;le;2 months; P = 0.0296), and was negatively correlated with disease duration within the first year (r = -0.2518, P = 0.0282). hBD-3 expression was higher in lesions from patients with the lymphocutaneous form than in those with the fixed cutaneous form (P = 0.0120). hBD-3 expression was also significantly negatively correlated with fungal burden in lesions (r = -0.6008, P &amp;lt; 0.0001).2. Correlation of hBD-3 expression with local and systemic inflammatory responses in sporotrichosis lesions: hBD-3 expression was significantly positively correlated with the area of dermal MPO+ neutrophil infiltration (r = 0.5922, P = 0.0011), but showed no significant correlation with the infiltration of CD4+ T cells (r = 0.1038, P = 0.6633), CD8+ T cells (r = -0.2722, P = 0.2457) or CD68+ macrophages (r = 0.1434, P = 0.5701). Among systemic inflammatory markers, local hBD-3 expression in lesions showed no correlation with plasma levels of CRP or most chemokines (all P &amp;gt; 0.05), and was negatively correlated only with plasma CXCL3 levels (r = -0.6214, P = 0.0155).3. Correlation of hBD-3 expression w clinical manifestations in sporotrichosis lesions: hBD-3 expression was significantly higher in lesions with ulceration or erosion than those without (P &amp;lt; 0.0001). Univariable logistic regression showed that the percentage of hBD-3 positive area was significantly associated with ulcer formation in lesions (OR = 1.249, 95% CI: 1.087&amp;ndash;1.434, P = 0.0017). After adjustment for age, sex, disease duration, and clinical type, this association remained significant (adjusted OR = 1.278, 95% CI: 1.093&amp;ndash;1.493, P = 0.0021).</dc:description>
  <dc:subject>Sporotrichosis; Human β-defensin-3; Antimicrobial peptide; Subcutaneous mycosis; Clinical correlation</dc:subject>
  <dc:creator>曲昱颖</dc:creator>
  <dc:creator>崔岩</dc:creator>
  <dc:rights>PUBLIC</dc:rights>
  <dc:rights>https://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>